Skip To Main Content
or Pfizer on Muck Rack

or Pfizer

As seen in: MarketScreener
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to or Pfizer’s profile

Articles by or Pfizer

ARVINAS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) | MarketScreener

|
By or Pfizer, uncertainties. As a, or mCRPC, with Pfizer
| MarketScreener
The following discussion and analysis is meant to provide material information relevant to an assessment of the financial condition and results of operations of our company, including an evaluation of the amount and certainty of cash flows from operations and from outside sources, so as to allow investors to better view our company from management's perspective.
Open in Who Shared Issue with article?

SANGAMO THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener

|
By Isaralgagene civaparvovec, Giroctocogene fitelparvovec, or Pfizer, to Sangamo
| MarketScreener
(SGMO) Real-time Estimate Cboe BZX - 10:52:44 2023-02-23 am EST 2.955 USD +1.55% 06:12a SANGAMO THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) AQ 02/22 Sangamo : Q4 Earnings Snapshot AQ 02/22 Sangamo Therapeutics : Corporate Presentation PU Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
Open in Who Shared Issue with article?
Show More